Company Overview

Update
Founded:
2000
Headquarters:
Berkeley, CA
Funding:
$37M
Categories:
Biotechnology

Aduro BioTech is a development-stage biopharmaceutical company engaged in the development of early-stage cancer therapies.

Description

Update

Aduro BioTech, Inc., a development stage biopharmaceutical company, engages in the development of early stage cancer therapies. The company focuses on the development of its minimally invasive NT and TNT cancer treatment systems, which use iron oxide nano-particles that generate heat when exposed to an externally applied magnetic field and kills tumor cells without the toxicity or collateral damage. It offers therapies for breast, prostate, colorectal, lung, pancreas, ovarian, and head and neck cancers. The company was formerly known as Oncologic, Inc. and changed its name to Aduro BioTech, Inc. in June 2008. Aduro BioTech, Inc. was founded in 2000 and is headquartered in Berkeley, California.

Current Team (8)

Update

Board Members and Advisors (5)

Update

Funding Rounds (7) - $37M

Update

Investors (1)

Update
  • Be3de5609febe52b26115f5be1ca3129

    Morningside Group

    Morningside Group is a private investment group founded in 1986 by the Chan family of Hong Kong.

Offices/Locations (1)

Update
  • Office

    626 Bancroft Way

    #3C

    Berkeley, CA 94710

    USA